APA (7th ed.) Citation

JS, E., S, A., E, S., J, M., R, G., & SM, R. (2018). EMPIRE-CF: A phase II randomized placebo-controlled trial of once-daily, oral acebilustat in adult patients with cystic fibrosis - Study design and patient demographics. Contemporary clinical trials, 72, 86. https://doi.org/10.1016/j.cct.2018.07.014

Chicago Style (17th ed.) Citation

JS, Elborn, Ahuja S, Springman E, Mershon J, Grosswald R, and Rowe SM. "EMPIRE-CF: A Phase II Randomized Placebo-controlled Trial of Once-daily, Oral Acebilustat in Adult Patients with Cystic Fibrosis - Study Design and Patient Demographics." Contemporary Clinical Trials 72 (2018): 86. https://doi.org/10.1016/j.cct.2018.07.014.

MLA (9th ed.) Citation

JS, Elborn, et al. "EMPIRE-CF: A Phase II Randomized Placebo-controlled Trial of Once-daily, Oral Acebilustat in Adult Patients with Cystic Fibrosis - Study Design and Patient Demographics." Contemporary Clinical Trials, vol. 72, 2018, p. 86, https://doi.org/10.1016/j.cct.2018.07.014.